Emerald Advisers, LLC Acadia Pharmaceuticals Inc Transaction History

Emerald Advisers, LLC

$2.53 Billion
Q2 2025

A detailed history of Emerald Advisers, LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Emerald Advisers, LLC holds 592,358 shares of ACAD stock, worth $12.4 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares

592,358

Previous 815,905 27.4%

Holding current value

$12.4 Million

Previous $13.6 Million 5.72%

% of portfolio

0.5%

Previous 0.67%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 04, 2025	SELL	$14.1 - $22.95 $3.15 Million - $5.13 Million	-223,547 Reduced 27.4%	592,358 $12.8 Million
Q1 2025 May 01, 2025	SELL	$16.61 - $20.29 $152,214 - $185,937	-9,164 Reduced 1.11%	815,905 $13.6 Million
Q4 2024 Feb 11, 2025	SELL	$14.29 - $18.76 $82,310 - $108,057	-5,760 Reduced 0.69%	825,069 $15.1 Million
Q3 2024 Oct 29, 2024	BUY	$15.14 - $19.14 $333,049 - $421,041	21,998 Added 2.72%	830,829 $12.8 Million
Q2 2024 Aug 06, 2024	SELL	$14.62 - $18.42 $12.3 Million - $15.5 Million	-842,293 Reduced 51.01%	808,831 $13.1 Million
Q1 2024 May 08, 2024	BUY	$17.79 - $30.86 $98,894 - $171,550	5,559 Added 0.34%	1,651,124 $30.5 Million
Q4 2023 Feb 05, 2024	SELL	$20.78 - $31.77 $737,419 - $1.13 Million	-35,487 Reduced 2.11%	1,645,565 $51.5 Million
Q3 2023 Oct 26, 2023	BUY	$20.84 - $33.47 $1.34 Million - $2.15 Million	64,100 Added 3.96%	1,681,052 $35 Million
Q2 2023 Jul 25, 2023	BUY	$17.8 - $25.65 $2.14 Million - $3.09 Million	120,392 Added 8.04%	1,616,952 $38.7 Million
Q1 2023 May 04, 2023	BUY	$16.32 - $20.92 $2.85 Million - $3.65 Million	174,414 Added 13.19%	1,496,560 $28.2 Million
Q4 2022 Feb 03, 2023	SELL	$14.2 - $18.63 $106,216 - $139,352	-7,480 Reduced 0.56%	1,322,146 $21 Million
Q3 2022 Oct 25, 2022	BUY	$14.11 - $18.27 $6.62 Million - $8.57 Million	468,877 Added 54.47%	1,329,626 $21.8 Million
Q2 2022 Jul 29, 2022	BUY	$13.01 - $27.22 $936,863 - $1.96 Million	72,011 Added 9.13%	860,749 $12.1 Million
Q1 2022 Apr 29, 2022	BUY	$20.94 - $27.5 $1.5 Million - $1.96 Million	71,420 Added 9.96%	788,738 $19.1 Million
Q4 2021 Feb 02, 2022	BUY	$16.79 - $27.09 $12 Million - $19.4 Million	717,318 New	717,318 $16.7 Million

Others Institutions Holding ACAD

# of Institutions

348

Shares Held

163M

Call Options Held

811K

Put Options Held

334K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $3.39B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Emerald Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Emerald Advisers, LLC with notifications on news.

Account

Emerald Advisers, LLC Acadia Pharmaceuticals Inc Transaction History